🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine whether pretreatment with two doses of acamprosate ...
Status
Completed
Location
Substance Abuse Treatment Unit, University of Connecticut
Start Date
TBD
Trial ID
NCT00004552
Treatments Being Tested
The purpose of this study is to test how tolerable and effective acamprosat...
Status
Terminated
Location
Virginia Commonwealth University Medical Center
Start Date
2005-06
Trial ID
NCT00249379
Treatments Being Tested
The aim of this study was to compare the effect of manual based cognitive t...
Status
Completed
Location
National Public Health Institute, Department of Mental Health and Alcohol Research
Start Date
2000-09
Trial ID
NCT00435435
Treatments Being Tested
This study will examine whether a new drug called acamprosate can be helpfu...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2005-03
Trial ID
NCT00106106
Treatments Being Tested
The aim of this study is to utilize neurophysiologic assessments, behaviora...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2016-01
Trial ID
NCT02998151
Treatments Being Tested
Recent pharmacotherapy research in autism spectrum disorders (ASD) has succ...
Status
Completed
Location
Cincinnati Children's Hospital Medical Center
Start Date
2013-07-02
Trial ID
NCT01813318
Treatments Being Tested
This study is designed to evaluate anxious patients who are only partially ...
Status
Completed
Location
SUNY Upstate Medical University Psychiatry Dept.
Start Date
2006-06
Trial ID
NCT00591565
Treatments Being Tested
Once someone becomes dependent on alcohol (alcoholic), the risks of complic...
Status
Completed
Location
University of Bristol, Bristol PCT.
Start Date
2009-11
Trial ID
NCT00855699
Treatments Being Tested
Medications for Alcohol use disorder (MAUD) (acamprosate, naltrexone, and d...
Status
Terminated
Location
Yale School of Medicine
Start Date
2020-01-01
Trial ID
NCT04287790
In 2004, acamprosate was approved in the U.S. for abstinence maintenance, b...
Status
Completed
Location
Mayo Clinic
Start Date
2008-05
Trial ID
NCT00662571
Treatments Being Tested